NewsMedTrace receives U.S. patent for diagnosing the human heartMedTrace receives U.S. patent for diagnosing the human heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the...
NewsCEO stepping down; MedTrace will intensify its efforts to complete the phase 3 clinical trialCEO stepping down MedTrace will intensify its efforts to complete the phase 3 clinical trial MedTrace will intensify efforts to complete its phase 3 clinical...
ClinicalNews15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans”...
ClinicalConferencesNewsMedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-waterMedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water On October 17, 2022, MedTrace hosted a...
NewsPeopleMedTrace inaugurates U.S. headquarters in downtown MinneapolisMedTrace inaugurates U.S. headquarters in downtown Minneapolis Danish-born MedTrace is opening its new U.S. headquarters in Minneapolis’ IDS Center on September 7, 2022. The company...
ClinicalNewsMedTrace Announces First Subject Scanned in Phase 3 Clinical TrialMedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark...
NewsPeopleMedTrace expands management with financial strategist as CFOMedTrace expands management and appoints financial strategist heavyweight as CFO Ann Kristin Led, former Exec. Vice President of Finance and Strategy at pharma company MC2...
ClinicalNewsMedTrace announces IND approval of RAPID-WATER phase 3 clinical trialMedTrace Pharma announces IND approval with the initiation of RAPID-WATER phase 3 clinical trial MedTrace Pharma A/S announced today the FDA approval of the company’s...
ClinicalNewsMedTrace Pharma takes step towards CE markingMedTrace Pharma takes step towards CE marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with...
ClinicalNewsMedTrace Installs P3 System at Sahlgrenska University HospitalMedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation...
NewsPeopleInvestors inject $30 million into Danish medical imaging companyInvestors inject $30 million into Danish medical imaging company Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest are the main investors injecting nearly $30...
ClinicalNewsFirst patient imaged with MedTrace technologyFirst patient imaged with MedTrace technology The first PET scans with 15O-water generated with a novel production and administration system from the Danish company MedTrace...
ClinicalNewsMedTrace to partner with Mayo Clinic in oncology studyMedTrace to partner with Mayo Clinic in oncology study As part of the recently closed equity fundraising, MedTrace also signed a know-how license agreement with...
NewsPeopleMedTrace feature article in BørsenMedTrace feature article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt...
NewsPeopleMedTrace accomplishes funding of DKK 21MMedTrace accomplishes funding of DKK 21M MedTrace Pharma A/S has completed a capital raise against equity to advance our preparations for the upcoming clinical trial...
ClinicalNewsPutting the low radiation dose of 15O-water in perspectivePutting the low radiation of 15O-water in perspective Tracers are radioactive compounds that doctors inject into patients to diagnose various diseases by, for example, following...
ClinicalNewsManufacturing PartnershipManufacturing Partnership with A/S Kurt Hansen In preparation for our future production of hardware systems, we have partnered with A/S Kurt Hansen from Svendborg, Denmark...
ConferencesNewsASNC Young Investigator’s AwardHans receives the Young Investigator’s Award at ASNC Hans Harms, our VP of Software Development, received the Young Investigator’s Award at the ASNC meeting this...
NewsPeopleJapanese Country ManagerJapanese Country Manager on board Since the beginning of our activities in Japan, we have had the pleasure of working together with Yumi Murakami from...
ConferencesNewsSNMMI ConferenceMedTrace Pharma Exhibits at SNMMI The annual meeting of the Society of Nuclear Medicine and Molecular Imaging (#SNMMI) takes place in Anaheim, California this year...
